T17	Exp 139 150	The effects
T18	Exp 222 229	the CD4
T19	Exp 360 374	the production
T20	Exp 382 395	the cytokines
T21	Exp 439 465	the proliferative response
T22	Exp 489 503	the production
T23	Exp 647 661	the production
T24	Exp 709 723	the production
T25	Exp 755 766	the effects
T26	Exp 793 801	the mode
T27	Exp 828 836	the IL-4
T28	Exp 926 940	the NF-kappa B
T29	Exp 999 1019	the kappa B sequence
T30	Exp 1050 1054	When
T31	Exp 1171 1191	the kappa B sequence
T32	Exp 1259 1270	the binding
T33	Exp 1310 1330	the kappa B sequence
T34	Exp 1394 1405	Our results
T35	Exp 1414 1418	that
T36	Exp 1419 1429	the target
T37	Exp 1463 1494	the signal transduction pathway
T38	Exp 1506 1520	the activation
T39	Exp 1551 1565	the inhibition
T40	Exp 1569 1598	the T cell activation signals
T41	Exp 1693 1697	when
T42	Exp 1635 1656	the complex formation
T43	Exp 1698 1707	the cells
T44	Exp 1773 1775	It
T45	Exp 1792 1796	that
T46	Exp 1845 1867	the activation pathway
T1	Protein 226 229	CD4
T2	Protein 507 511	IL-4
T3	Protein 516 520	IL-5
T4	Protein 665 669	IL-4
T5	Protein 674 678	IL-5
T6	Protein 832 836	IL-4
T7	Protein 841 845	IL-5
T8	Protein 942 945	p50
T9	Protein 946 949	p50
T10	Protein 1145 1148	p50
T11	Protein 1149 1152	p65
T12	Protein 1286 1289	p50
T13	Protein 1290 1293	p65
